Work

1040O Phase II trial of ipilimumab, nivolumab and tocilizumab for unresectable metastatic melanoma

Year: 2021

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2021.08.1425

Authors: J.S. Weber, T. Muramatsu, O. Hamid, J. Mehnert, F.S. Hodi, S. Krishnarajapet, S. Malatyali, E. Buchbinder, J. Goldberg, R. Sullivan, M. Faries, I. Mehmi

Institutions: NYU Langone’s Laura and Isaac Perlmutter Cancer Center, Angeles Clinic and Research Institute, Dana-Farber Cancer Institute, Massachusetts General Hospital

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3204315935

FWCI: 1.475

Cites:

Cited by: 23

Related to: 10